Post-effective amendment to a registration statement that is not immediately effective upon filing

Net Earnings (Loss) Per Share (Tables)

v3.22.1
Net Earnings (Loss) Per Share (Tables)
3 Months Ended 12 Months Ended
Apr. 03, 2022
Jan. 02, 2022
Earnings Per Share [Abstract]    
Reconciliation of net loss per common share
The following table sets forth the computation of the Company’s basic and diluted net EPS of common stock for the periods presented below (in thousands, except share and per share amount):

 
 
  
For the Quarters Ended
 
 
  
April 3,
2022
 
  
March 31,
2021
 
Numerator:
  
     
  
     
Net income (loss) attributable to common stockholders — basic
   $ 42,707      $ (16,165
Increase in fair value of Private Placement Warrants
     (67,800      —    
    
 
 
    
 
 
 
Net loss attributable to common stockholders — Diluted
   $ (25,093    $ (16,165
    
 
 
    
 
 
 
Denominator:
                 
Weighted-average shares outstanding used in computing net income (loss) per share of common stock, basic
     151,648,439        95,816,889  
Dilutive effect of Private Placement Warrants
     1,690,023        —    
    
 
 
    
 
 
 
Weighted-average shares outstanding used in computing net loss per share of common stock, diluted
     153,338,462        95,816,889  
    
 
 
    
 
 
 
Net income (loss) per share of common stock:
                 
Basic
   $ 0.28      $ (0.17
Diluted
   $ (0.16    $ (0.17
The
 following table sets forth the computation of the Company’s basic and diluted net loss per share of common stock for the periods presented below (in thousands, except share and per share amount):
 
    
Fiscal Years
 
    
2021
    
2020
 
Numerator:
                 
Net loss attributable to common stockholders — basic and diluted
   $ (125,874    $ (39,650
Denominator:
                 
Weighted-average shares outstanding used in computing net loss per
share of common stock, basic and diluted
     117,218,893        80,367,324  
Net loss per share of common stock:
                 
Basic and diluted
   $ (1.07    $ (0.49
Schedule of anti-dilutive securities excluded from computation of diluted earning per share As the Company reported net loss for the quarter ended March 31, 2021, all of these potentially dilutive securities were anti-dilutive.
 
  
April 3,
2022
 
  
March 31,
2021
 
Stock options outstanding
     5,536,905        730,176  
Restricted stock units outstanding
     917,079        —    
Employee stock purchase plan estimated shares
     78,198        —    
As the Company reported losses for the periods presented, all of these potentially dilutive securities were anti-dilutive and are excluded in the computation of diluted net loss per share. Accordingly, the diluted net loss per share equals to the basic net loss per share.
    
As of
 
    
January 2,
2022
    
December 31,
2020
 
Stock options outstanding
     5,753,005        1,428,980  
Restricted stock units
     535,449        —    
Private Placement Warrants
     6,000,000        —    
Public Warrants
     4,322,106        —    
Employee stock purchase plan estimated shares
     47,379        —